NORDTREAT Prospective Study on Inflammatory Bowel Disease
Launched by UNIVERSITY OF SOUTHERN DENMARK · Jun 9, 2022
Trial Information
Current as of November 10, 2025
Recruiting
Keywords
ClinConnect Summary
The NORDTREAT study is a clinical trial aimed at understanding and improving the diagnosis and treatment of inflammatory bowel diseases (IBD), which include Crohn's disease and ulcerative colitis. These conditions can cause ongoing symptoms like diarrhea, abdominal pain, and fatigue, and may lead to serious complications if not properly managed. The researchers are looking for specific markers in the body that can help doctors diagnose IBD more accurately and predict how the disease may progress in different patients. This is important because early diagnosis can help prevent more severe health issues down the line.
To participate in this study, individuals must be adults (18 years and older) who have been referred to the hospital with a suspicion of IBD. Participants will need to give their written consent to take part. The study is currently recruiting and aims to make a real difference in how IBD is understood and treated. If you or someone you know is experiencing symptoms of IBD and is looking for support, this study may provide valuable insights and contribute to better healthcare for all IBD patients.
Gender
ALL
Eligibility criteria
- To be included in the study, the participants must meet the following criteria:
- Inclusion Criteria:
- • Referred on the suspicion of inflammatory bowel disease
- • Adult (+18 years of age)
- • Written informed consent to participate in the study
- Exclusion Criteria:
- • A previous known diagnosis of Crohn's disease, ulcerative colitis or IBD-U
- • Unable to provide informed consent
- • Unable to comply with protocol requirements (e.g., for reasons including alcohol and/or recreational drug abuse)
About University Of Southern Denmark
The University of Southern Denmark (SDU) is a prominent research institution dedicated to advancing knowledge and innovation across various fields, including health sciences. As a clinical trial sponsor, SDU is committed to conducting rigorous and ethically sound research aimed at improving patient outcomes and informing clinical practices. Leveraging its multidisciplinary expertise and state-of-the-art facilities, SDU collaborates with healthcare professionals, industry partners, and regulatory bodies to develop and execute clinical trials that adhere to the highest standards of scientific integrity and compliance. Through its research initiatives, SDU seeks to contribute to the global body of medical knowledge and enhance the quality of healthcare delivery.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Odense, Denmark
örebro, Sweden
Tønsberg, Norway
Oslo, Norway
Linköping, Sweden
Reykjavík, Iceland
Drammen, Norway
Stockholm, Sweden
Grålum, Norway
Skien, Norway
Eksjö, Region Jönköpings Län, Sweden
Stockholm, Region Stockholm, Sweden
Linköping, Region östergötland, Sweden
örebro, örebro Län, Sweden
Aabenraa, Denmark
Esbjerg, Denmark
Svendborg, Denmark
Vejle, Denmark
Uppsala, Region Uppsala, Sweden
Eksjö, Sweden
Patients applied
Trial Officials
Jens Kjeldsen, Professor
Principal Investigator
Odense University Hospital
Vibeke Andersen, Professor
Principal Investigator
University Hospital of Southern Denmark, Aabenraa
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials